Nova Patents
AT450615T

Compositions and methods of treating disease with fgfr fusion proteins

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

38 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
70147905United States of AmericaP
72940105United States of AmericaP
75739806United States of AmericaP
80000506United States of AmericaP
2006028597United States of AmericaW

Members38

Family members, oldest first
DocumentOfficeKind
AU2006272759A1AustraliaA1
CA2614039A1CanadaA1
WO2007014123A2World Intellectual Property Organization (WIPO)A2
WO2007014123A3World Intellectual Property Organization (WIPO)A3
EP1910542A2European Patent Office (EPO)A2
US2008171689A1United States of AmericaA1
JP2008222711AJapanA
HK1118857AHong Kong, ChinaA
EP2083081A1European Patent Office (EPO)A1
EP1910542B1European Patent Office (EPO)B1
AT450615TThis recordAustriaT
ATE450615T1AustriaT1
DE602006010874D1GermanyD1
US7678890B2United States of AmericaB2
ES2336832T3SpainT3
US2010158911A1United States of AmericaA1
NZ565511ANew ZealandA
US7982014B2United States of AmericaB2
US2011281302A1United States of AmericaA1
JP4822371B1JapanB1
AU2006272759B2AustraliaB2
US8173134B2United States of AmericaB2
US2012301921A1United States of AmericaA1
JP2013017484AJapanA
US2013065276A1United States of AmericaA1
US8501191B2United States of AmericaB2
US8580936B2United States of AmericaB2
US2013324701A1United States of AmericaA1
US2014140995A1United States of AmericaA1
JP2014519308AJapanA
JP2014240413AJapanA
CA2614039CCanadaC
US9173957B2United States of AmericaB2
US9192683B2United States of AmericaB2
JP5889505B2JapanB2
US2016096876A1United States of AmericaA1
JP6110091B2JapanB2
US2017349643A1United States of AmericaA1